Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kodiak Sciences (KOD) Common Equity (2016 - 2026)

Kodiak Sciences filings provide 11 years of Common Equity readings, the most recent being $112.1 million for Q1 2026.

  • Quarterly Common Equity rose 2.99% to $112.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $112.1 million through Mar 2026, up 2.99% year-over-year, with the annual reading at $157.4 million for FY2025, 4.72% up from the prior year.
  • Common Equity hit $112.1 million in Q1 2026 for Kodiak Sciences, down from $157.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $597.4 million in Q1 2022 and bottomed at $23.7 million in Q3 2025.
  • Average Common Equity over 5 years is $271.0 million, with a median of $241.2 million recorded in 2024.
  • Peak annual rise in Common Equity hit 4.72% in 2025, while the deepest fall reached 87.22% in 2025.
  • Kodiak Sciences' Common Equity stood at $436.2 million in 2022, then crashed by 39.06% to $265.8 million in 2023, then plummeted by 43.45% to $150.3 million in 2024, then rose by 4.72% to $157.4 million in 2025, then decreased by 28.77% to $112.1 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's Common Equity are $112.1 million (Q1 2026), $157.4 million (Q4 2025), and $23.7 million (Q3 2025).